BiomX Inc. announced that Yaron Breski and Erez Chimovits resigned from the Board of Directors of the company, effective immediately. Messrs. Breski’s and Chimovits’ resignations do not involve any disagreement on any matter relating to the Company, its management, the Board or any committee thereof. The Board appointed Alan C. Moses, MD and Paul J. Sekhri to serve as Class I Directors of the Company, with terms expiring at the Company’s 2021 annual meeting of stockholders, in order to fill the vacancies caused by Breski and Chimovits’ resignations. Mr. Sekhri was also elected as the Chairperson of the compensation committee of the Board. Dr. Moses served as the Global Chief Medical Officer of Novo Nordisk A/S from 2013 until his retirement in 2018. Mr. Sekhri has been the President and Chief Executive Officer of eGenesis Inc. since January 2019.